Afya Limited (NASDAQ:AFYA) Declares $0.23 — Dividend

Afya Limited (NASDAQ:AFYAGet Free Report) announced a — dividend on Thursday, March 13th, NASDAQ Dividends reports. Stockholders of record on Wednesday, March 26th will be given a dividend of 0.232 per share on Friday, April 4th. The ex-dividend date of this dividend is Wednesday, March 26th.

Afya has a dividend payout ratio of 12.4% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Afya to earn $1.91 per share next year, which means the company should continue to be able to cover its $0.23 annual dividend with an expected future payout ratio of 12.0%.

Afya Stock Down 0.3 %

AFYA opened at $17.93 on Monday. Afya has a fifty-two week low of $14.52 and a fifty-two week high of $20.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. The company has a market capitalization of $1.68 billion, a P/E ratio of 14.46, a P/E/G ratio of 0.29 and a beta of 0.82. The stock has a fifty day moving average of $16.72 and a 200-day moving average of $16.48.

Analyst Ratings Changes

A number of research firms have recently weighed in on AFYA. JPMorgan Chase & Co. dropped their target price on Afya from $25.00 to $20.50 and set a “neutral” rating for the company in a report on Friday, January 17th. Citigroup reaffirmed a “sell” rating and issued a $15.00 price target (down previously from $18.00) on shares of Afya in a research note on Friday, January 31st. Morgan Stanley downgraded Afya from an “equal weight” rating to an “underweight” rating and dropped their price target for the company from $19.00 to $17.00 in a research note on Tuesday, March 11th. Finally, The Goldman Sachs Group assumed coverage on Afya in a research note on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 price target for the company. Three analysts have rated the stock with a sell rating and two have issued a hold rating to the stock. According to data from MarketBeat, Afya currently has a consensus rating of “Reduce” and a consensus price target of $17.60.

Get Our Latest Stock Report on Afya

About Afya

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Featured Stories

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.